Autopsy report · NCT00232167

Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression

“Please see Detailed Description below for termination reason.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 5 months before it stopped.
• 380 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Neurocrine Biosciences

Sponsor type

Industry

Conditions

Insomnia; Depression

Interventions

Indiplon; Sertraline

Participants

380

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.